WallStreetZenWallStreetZen

NASDAQ: SUPN
Supernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Supernus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frederick M. HudsonDirector2026-01-0915,000$12.98
$194.70kBuy
Frank MottolaSVP Chief Tech. Ops. Officer2025-12-1915,000$50.47
$757.05kSell
Frank MottolaSVP Chief Tech. Ops. Officer2025-12-195,000$39.40
$197.00kBuy
Frank MottolaSVP Chief Tech. Ops. Officer2025-12-195,000$50.22
$251.10kSell
Frank MottolaSVP Chief Tech. Ops. Officer2025-12-1915,000$25.30
$379.50kBuy
Padmanabh P. BhattSr. VP of IP CSO2025-12-18710$44.44
$31.55kSell
Charles W. Newhall IiiDirector2025-11-2115,000$12.98
$194.70kBuy
Jack A. KhattarPresident CEO2025-10-0958,371$50.55
$2.95MSell
Jack A. KhattarPresident CEO2025-10-091,529$51.46
$78.68kSell
Jack A. KhattarPresident CEO2025-10-0981,250$25.30
$2.06MBuy

1 of 9

SUPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SUPN insiders and whales buy or sell their stock.

SUPN Shareholders

What type of owners hold Supernus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter J. Barris20.68%11,859,518$587.28MInsider
Scott D. Sandell20.50%11,757,336$582.22MInsider
Forest Baskett20.49%11,746,274$581.68MInsider
Charles W. Newhall Iii18.77%10,760,894$532.88MInsider
Blackrock Inc15.17%8,698,410$430.75MInstitution
Vanguard Group Inc10.54%6,044,750$299.34MInstitution
Krishna Kittu Kolluri6.70%3,841,172$190.21MInsider
Nea Partners 11 LP6.66%3,820,625$189.20MInsider
New Enterprise Associates 11 LP6.66%3,820,625$189.20MInsider
Michael B. Sheffery6.64%3,806,814$188.51MInsider

1 of 3

SUPN vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SUPN45.48%54.52%Net BuyingNet Buying
HCM0.66%0.00%
BHC50.60%49.40%Net BuyingNet Buying
PBH68.85%31.15%Net SellingNet Selling
AVDL81.67%13.55%
View Top Pharmaceutical Stocks

Supernus Pharmaceuticals Stock Ownership FAQ

Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals (NASDAQ: SUPN) is owned by 100.60% institutional shareholders, 120.59% Supernus Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Supernus Pharmaceuticals shareholder, owning 11.86M shares representing 20.68% of the company. Peter J. Barris's Supernus Pharmaceuticals shares are currently valued at $582.30M.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.